GERN - Why Geron Stock Is Falling Today | Benzinga
Geron Corporation (NASDAQ:GERN) shares are trading lower Tuesday after FDA staff reviewers reportedly raised multiple safety concerns over Geron’s anemia drug, imetelstat.
The Details:
According to the Reuters report, FDA staff said the “clinical meaningfulness” of the clinical data was unclear and pointed to a high rate of low red blood cell counts in the study. FDA staff also reportedly said the study did not show a “disease-modifying effect.”
Geron shares are falling on heavy trading volume ...